• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将再构成的高密度脂蛋白作为治疗性药物递送载体。

Reconstituted HDL as a therapeutic delivery device.

机构信息

Department of Biochemistry and Molecular Biology, University of Nevada, Reno, Reno, NV 89557, United States of America.

Department of Biochemistry and Molecular Biology, University of Nevada, Reno, Reno, NV 89557, United States of America.

出版信息

Biochim Biophys Acta Mol Cell Biol Lipids. 2021 Nov;1866(11):159025. doi: 10.1016/j.bbalip.2021.159025. Epub 2021 Aug 8.

DOI:10.1016/j.bbalip.2021.159025
PMID:34375767
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9336189/
Abstract

Studies of "pre β" high density lipoprotein (HDL) and reconstituted HDL (rHDL) have contributed to our understanding of the Reverse Cholesterol Transport pathway. The relative ease with which discoidal rHDL can be generated in vitro has led to novel applications including a) infusion of rHDL into patients to promote regression of atherosclerosis; b) use of rHDL as a miniature membrane for integration of transmembrane proteins in a native-like conformation and c) incorporation of hydrophobic bioactive molecules into rHDL, creating a delivery device. The present review is focused on bioactive agent containing rHDL. The broad array of hydrophobic bioactive molecules successfully incorporated into these particles is discussed, as well as the use of natural lipids and synthetic lipid analogs to confer distinctive binding activity. This technology remains in its infancy with the full potential of these simple, yet elegant, nanoparticles still to be discovered.

摘要

对“前 β”高密度脂蛋白(HDL)和重组 HDL(rHDL)的研究促进了我们对胆固醇逆向转运途径的理解。盘状 rHDL 在体外很容易生成,这导致了一些新的应用,包括:a)将 rHDL 输注到患者体内以促进动脉粥样硬化的消退;b)将 rHDL 用作整合跨膜蛋白的微型膜,以形成类似天然的构象;c)将疏水性生物活性分子掺入 rHDL 中,形成递药装置。本综述重点关注含有生物活性物质的 rHDL。讨论了成功掺入这些颗粒的广泛的疏水性生物活性分子,以及使用天然脂质和合成脂质类似物来赋予独特的结合活性。该技术仍处于起步阶段,这些简单而优雅的纳米颗粒的全部潜力仍有待发现。

相似文献

1
Reconstituted HDL as a therapeutic delivery device.将再构成的高密度脂蛋白作为治疗性药物递送载体。
Biochim Biophys Acta Mol Cell Biol Lipids. 2021 Nov;1866(11):159025. doi: 10.1016/j.bbalip.2021.159025. Epub 2021 Aug 8.
2
Sterically stabilized recombined HDL composed of modified apolipoprotein A-I for efficient targeting toward glioma cells.立体稳定的重组富含载脂蛋白 A-I 的高密度脂蛋白,用于高效靶向神经胶质瘤细胞。
Drug Deliv. 2020 Dec;27(1):530-541. doi: 10.1080/10717544.2020.1745330.
3
Evaluation of reconstituted high-density lipoprotein (rHDL) as a drug delivery platform - a detailed survey of rHDL particles ranging from biophysical properties to clinical implications.重组高密度脂蛋白(rHDL)作为药物递送平台的评估——对rHDL颗粒从生物物理性质到临床意义的详细综述。
Nanomedicine. 2016 Oct;12(7):2161-2179. doi: 10.1016/j.nano.2016.05.009. Epub 2016 May 26.
4
The Composition of Reconstituted High-Density Lipoproteins (rHDL) Dictates the Degree of rHDL Cargo- and Size-Remodeling via Direct Interactions with Endogenous Lipoproteins.重组高密度脂蛋白(rHDL)的组成决定了其通过与内源性脂蛋白的直接相互作用对 rHDL 载脂蛋白和大小进行重塑的程度。
Bioconjug Chem. 2019 Oct 16;30(10):2634-2646. doi: 10.1021/acs.bioconjchem.9b00552. Epub 2019 Sep 19.
5
Cell cholesterol efflux to reconstituted high-density lipoproteins containing the apolipoprotein A-IMilano dimer.细胞胆固醇向含有载脂蛋白A-米兰二聚体的重组高密度脂蛋白的流出。
Biochemistry. 1999 Dec 7;38(49):16307-14. doi: 10.1021/bi991246n.
6
Cholesterol mobilization by free and lipid-bound apoAI(Milano) and apoAI(Milano)-apoAII heterodimers.游离和脂质结合的载脂蛋白AI(米兰)及载脂蛋白AI(米兰)-载脂蛋白AII异二聚体对胆固醇的动员作用
Biochemistry. 2001 Mar 27;40(12):3666-73. doi: 10.1021/bi002141j.
7
Multifunctional Dextran Sulfate-Coated Reconstituted High Density Lipoproteins Target Macrophages and Promote Beneficial Antiatherosclerotic Mechanisms.多功能硫酸葡聚糖包被的重组高密度脂蛋白靶向巨噬细胞并促进有益的抗动脉粥样硬化机制。
Bioconjug Chem. 2017 Feb 15;28(2):438-448. doi: 10.1021/acs.bioconjchem.6b00600. Epub 2017 Jan 5.
8
Apolipoprotein AI tertiary structures determine stability and phospholipid-binding activity of discoidal high-density lipoprotein particles of different sizes.载脂蛋白AI三级结构决定不同大小盘状高密度脂蛋白颗粒的稳定性和磷脂结合活性。
Protein Sci. 2009 May;18(5):921-35. doi: 10.1002/pro.101.
9
Artificial High Density Lipoprotein Nanoparticles in Cardiovascular Research.人工高密度脂蛋白纳米颗粒在心血管研究中的应用。
Molecules. 2019 Aug 2;24(15):2829. doi: 10.3390/molecules24152829.
10
Lipid exchange of apolipoprotein A-I amyloidogenic variants in reconstituted high-density lipoprotein with artificial membranes.载脂蛋白 A-I 淀粉样变体在人工膜重建的高密度脂蛋白中的脂质交换。
Protein Sci. 2024 May;33(5):e4987. doi: 10.1002/pro.4987.

引用本文的文献

1
Preliminary Evaluation of 3D-Printed Alginate/Gelatin Scaffolds for Protein Fast Release as Suitable Devices for Personalized Medicine.用于蛋白质快速释放的3D打印藻酸盐/明胶支架作为个性化医疗适用装置的初步评估
Biomedicines. 2025 Jun 2;13(6):1365. doi: 10.3390/biomedicines13061365.
2
High-Density Lipoprotein in Patients with Diabetic Kidney Disease: Friend or Foe?糖尿病肾病患者中的高密度脂蛋白:是友还是敌?
Int J Mol Sci. 2025 Feb 16;26(4):1683. doi: 10.3390/ijms26041683.
3
Foam fractionation studies of recombinant human apolipoprotein A-I.

本文引用的文献

1
Barth syndrome: cardiolipin, cellular pathophysiology, management, and novel therapeutic targets.巴特综合征:心磷脂、细胞病理生理学、管理和新的治疗靶点。
Mol Cell Biochem. 2021 Mar;476(3):1605-1629. doi: 10.1007/s11010-020-04021-0. Epub 2021 Jan 7.
2
Characterization of Spore Proteins Using a Nanoscaffold Vaccine Platform.利用纳米支架疫苗平台对孢子蛋白进行表征。
Front Immunol. 2020 Jun 23;11:1264. doi: 10.3389/fimmu.2020.01264. eCollection 2020.
3
Reconfiguring Nature's Cholesterol Accepting Lipoproteins as Nanoparticle Platforms for Transport and Delivery of Therapeutic and Imaging Agents.
重组人载脂蛋白 A-I 的泡沫分离研究。
Biochim Biophys Acta Biomembr. 2024 Oct;1866(7):184375. doi: 10.1016/j.bbamem.2024.184375. Epub 2024 Aug 10.
4
Lipid exchange of apolipoprotein A-I amyloidogenic variants in reconstituted high-density lipoprotein with artificial membranes.载脂蛋白 A-I 淀粉样变体在人工膜重建的高密度脂蛋白中的脂质交换。
Protein Sci. 2024 May;33(5):e4987. doi: 10.1002/pro.4987.
5
Molecular Dynamics and In Vitro Studies Elucidating the Tunable Features of Reconfigurable Nanodiscs for Guiding the Optimal Design of Curcumin Formulation.分子动力学和体外研究阐明可重构纳米盘的可调特性以指导姜黄素制剂的优化设计。
Bioengineering (Basel). 2024 Feb 29;11(3):245. doi: 10.3390/bioengineering11030245.
6
New Insights on the Uptake and Trafficking of Coenzyme Q.辅酶Q摄取与运输的新见解
Antioxidants (Basel). 2023 Jul 6;12(7):1391. doi: 10.3390/antiox12071391.
7
Isolation of recombinant apolipoprotein E4 N-terminal domain by foam fractionation.通过泡沫浮选分离重组载脂蛋白 E4 N 端结构域。
Protein Expr Purif. 2023 Oct;210:106319. doi: 10.1016/j.pep.2023.106319. Epub 2023 Jun 6.
8
Lipoprotein Particles as Shuttles for Hydrophilic Cargo.作为亲水性货物载体的脂蛋白颗粒
Membranes (Basel). 2023 Apr 28;13(5):471. doi: 10.3390/membranes13050471.
9
Hyaluronic Acid-Guided Cerasome Nano-Agents for Simultaneous Imaging and Treatment of Advanced Atherosclerosis.透明质酸引导的脂囊泡纳米载药系统用于动脉粥样硬化的联合诊疗
Adv Sci (Weinh). 2023 Feb;10(5):e2202416. doi: 10.1002/advs.202202416. Epub 2022 Dec 18.
10
Foam fractionation of a recombinant biosurfactant apolipoprotein.重组生物表面活性剂载脂蛋白的泡沫分离。
J Biotechnol. 2022 Jan 10;343:25-31. doi: 10.1016/j.jbiotec.2021.11.004. Epub 2021 Nov 19.
将天然胆固醇接受脂蛋白重新配置为用于治疗剂和成像剂运输与递送的纳米颗粒平台。
Nanomaterials (Basel). 2020 May 8;10(5):906. doi: 10.3390/nano10050906.
4
Coenzyme Q: Clinical Applications in Cardiovascular Diseases.辅酶Q:在心血管疾病中的临床应用
Antioxidants (Basel). 2020 Apr 22;9(4):341. doi: 10.3390/antiox9040341.
5
Assembly and Characterization of Biocompatible Coenzyme Q -Enriched Lipid Nanoparticles.生物相容的辅酶 Q 富集脂质纳米粒子的组装与表征。
Lipids. 2020 Mar;55(2):141-149. doi: 10.1002/lipd.12218. Epub 2020 Feb 19.
6
Dye binding assay reveals doxorubicin preference for DNA versus cardiolipin.染料结合测定法显示阿霉素优先与 DNA 而非心磷脂结合。
Anal Biochem. 2020 Apr 1;594:113617. doi: 10.1016/j.ab.2020.113617. Epub 2020 Feb 8.
7
Calcium-induced transformation of cardiolipin nanodisks.钙离子诱导心磷脂纳米盘的相变。
Biochim Biophys Acta Biomembr. 2019 May 1;1861(5):1030-1036. doi: 10.1016/j.bbamem.2019.03.005. Epub 2019 Mar 13.
8
Reconstituted Discoidal High-Density Lipoproteins: Bioinspired Nanodiscs with Many Unexpected Applications.重构的盘状高密度脂蛋白:具有许多意想不到应用的仿生纳米盘
Curr Atheroscler Rep. 2018 Nov 5;20(12):59. doi: 10.1007/s11883-018-0759-1.
9
Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial: A Randomized Clinical Trial.CER-001 动脉粥样硬化消退急性冠脉综合征试验中 CER-001,一种前β高密度脂蛋白类似物,对急性冠脉综合征后患者冠状动脉粥样硬化的连续输注的影响:一项随机临床试验。
JAMA Cardiol. 2018 Sep 1;3(9):815-822. doi: 10.1001/jamacardio.2018.2121.
10
Evaluation of cardiolipin nanodisks as lipid replacement therapy for Barth syndrome.评估心磷脂纳米盘作为Barth综合征脂质替代疗法的效果。
J Biomed Res. 2018 Mar 26;32(2):107-112. doi: 10.7555/JBR.32.20170094.